Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 41,297 | 5,442 | 14,189 | 5,874 | 15,044 |
| Gross Profit | 41,297 | 5,442 | 14,189 | 5,874 | 15,044 |
| Operating Expenses | 9,892 | 13,358 | 16,633 | 20,605 | 36,769 |
| Operating Income | 31,405 | -7,916 | -2,444 | -14,731 | -21,725 |
| Other Income | 376 | 534 | 744 | 865 | 1,127 |
| Pre-tax Income | 31,781 | -7,382 | -1,700 | -13,866 | -20,598 |
| Net Income Continuous | 31,520 | -7,382 | -1,700 | -13,866 | -20,888 |
| Net Income | $31,520 | $-7,382 | $-1,700 | $-13,866 | $-20,888 |
| EPS Basic Total Ops | 0.56 | -0.13 | -0.03 | -0.25 | -0.38 |
| EPS Basic Continuous Ops | 0.56 | -0.13 | -0.03 | -0.25 | -0.38 |
| EPS Diluted Total Ops | 0.56 | -0.13 | -0.03 | -0.25 | -0.38 |
| EPS Diluted Continuous Ops | 0.56 | -0.13 | -0.03 | -0.25 | -0.38 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.13 | -0.03 | -0.25 | -0.38 |
| EBITDA(a) | $31,405 | $-7,916 | $-2,444 | $-14,731 | $-21,725 |